Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383711235> ?p ?o ?g. }
- W4383711235 endingPage "639" @default.
- W4383711235 startingPage "633" @default.
- W4383711235 abstract "Ponatinib exhibits a high inhibition potency on wild-type and most mutated forms of the BCR:ABL1 kinase, but also a significant cardiovascular toxicity. Improving the efficacy/safety ratio should allow patients to safely draw benefit from the drug.Based on pharmacological findings and international guidelines on chronic myeloid leukemia and cardiovascular risk management, as well as on the most recent data collected in real-life studies and in a randomized phase II trial, we propose a decision-tree of dose selection of the drug.We distinguish (1) highly resistant patients according to poor previous response to second generation tyrosine kinase inhibitors (complete hematologic response or less) or to mutational status (T315I, E255V, alone or within compound mutations), requiring a starting daily dose of 45 mg, reduced to 15 or 30 mg according to the patient's profile, preferentially upon major molecular achievement (3-log reduction or MR3, BCR:ABL1 ≤ 0.1%IS); (2) less-resistant patients justifying an initial dose of 30 mg, reduced to 15 mg upon MR2 (BCR:ABL1 ≤ 1%IS) or preferentially MR3 in patients with a favorable safety profile; (3) intolerant patients to be treated by 15 mg." @default.
- W4383711235 created "2023-07-11" @default.
- W4383711235 creator A5004066423 @default.
- W4383711235 creator A5055797334 @default.
- W4383711235 creator A5070207000 @default.
- W4383711235 creator A5079480553 @default.
- W4383711235 creator A5085118674 @default.
- W4383711235 date "2023-07-27" @default.
- W4383711235 modified "2023-10-16" @default.
- W4383711235 title "Dose optimisation of ponatinib in chronic phase chronic myeloid leukemia" @default.
- W4383711235 cites W2110648386 @default.
- W4383711235 cites W2136065656 @default.
- W4383711235 cites W2140351909 @default.
- W4383711235 cites W2147109509 @default.
- W4383711235 cites W2339943063 @default.
- W4383711235 cites W2397234997 @default.
- W4383711235 cites W2526416288 @default.
- W4383711235 cites W2546480771 @default.
- W4383711235 cites W2548984342 @default.
- W4383711235 cites W2552922406 @default.
- W4383711235 cites W2571187593 @default.
- W4383711235 cites W2614344531 @default.
- W4383711235 cites W2763370961 @default.
- W4383711235 cites W2764064735 @default.
- W4383711235 cites W2766187515 @default.
- W4383711235 cites W2788900104 @default.
- W4383711235 cites W2790692615 @default.
- W4383711235 cites W2802207132 @default.
- W4383711235 cites W2808764596 @default.
- W4383711235 cites W2888514087 @default.
- W4383711235 cites W2920190085 @default.
- W4383711235 cites W2953204248 @default.
- W4383711235 cites W2973414734 @default.
- W4383711235 cites W2979500475 @default.
- W4383711235 cites W2979771750 @default.
- W4383711235 cites W2984264582 @default.
- W4383711235 cites W3009751715 @default.
- W4383711235 cites W3092607363 @default.
- W4383711235 cites W3136645236 @default.
- W4383711235 cites W3137918025 @default.
- W4383711235 cites W3194203975 @default.
- W4383711235 cites W3194213794 @default.
- W4383711235 cites W3197233987 @default.
- W4383711235 cites W3205344656 @default.
- W4383711235 cites W4200448927 @default.
- W4383711235 cites W4205414597 @default.
- W4383711235 cites W4210298192 @default.
- W4383711235 cites W4220730352 @default.
- W4383711235 cites W4220744517 @default.
- W4383711235 cites W4283015980 @default.
- W4383711235 cites W4288701141 @default.
- W4383711235 cites W4290841268 @default.
- W4383711235 cites W4293217929 @default.
- W4383711235 cites W4294307875 @default.
- W4383711235 cites W4296528992 @default.
- W4383711235 cites W4310107854 @default.
- W4383711235 cites W4310107918 @default.
- W4383711235 cites W4310161895 @default.
- W4383711235 cites W4310162533 @default.
- W4383711235 cites W4317717496 @default.
- W4383711235 cites W4318485463 @default.
- W4383711235 cites W4385722993 @default.
- W4383711235 doi "https://doi.org/10.1080/17474086.2023.2234084" @default.
- W4383711235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37427999" @default.
- W4383711235 hasPublicationYear "2023" @default.
- W4383711235 type Work @default.
- W4383711235 citedByCount "0" @default.
- W4383711235 crossrefType "journal-article" @default.
- W4383711235 hasAuthorship W4383711235A5004066423 @default.
- W4383711235 hasAuthorship W4383711235A5055797334 @default.
- W4383711235 hasAuthorship W4383711235A5070207000 @default.
- W4383711235 hasAuthorship W4383711235A5079480553 @default.
- W4383711235 hasAuthorship W4383711235A5085118674 @default.
- W4383711235 hasBestOaLocation W43837112351 @default.
- W4383711235 hasConcept C121608353 @default.
- W4383711235 hasConcept C126322002 @default.
- W4383711235 hasConcept C143998085 @default.
- W4383711235 hasConcept C170493617 @default.
- W4383711235 hasConcept C2776960273 @default.
- W4383711235 hasConcept C2777583451 @default.
- W4383711235 hasConcept C2778461978 @default.
- W4383711235 hasConcept C2778729363 @default.
- W4383711235 hasConcept C2778820342 @default.
- W4383711235 hasConcept C2779536868 @default.
- W4383711235 hasConcept C2780035454 @default.
- W4383711235 hasConcept C2780381907 @default.
- W4383711235 hasConcept C29730261 @default.
- W4383711235 hasConcept C42362537 @default.
- W4383711235 hasConcept C535046627 @default.
- W4383711235 hasConcept C71924100 @default.
- W4383711235 hasConcept C98274493 @default.
- W4383711235 hasConceptScore W4383711235C121608353 @default.
- W4383711235 hasConceptScore W4383711235C126322002 @default.
- W4383711235 hasConceptScore W4383711235C143998085 @default.
- W4383711235 hasConceptScore W4383711235C170493617 @default.
- W4383711235 hasConceptScore W4383711235C2776960273 @default.
- W4383711235 hasConceptScore W4383711235C2777583451 @default.
- W4383711235 hasConceptScore W4383711235C2778461978 @default.